Literature DB >> 14665664

Combined T4 and T3 therapy--back to the drawing board.

David S Cooper.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14665664     DOI: 10.1001/jama.290.22.3002

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.

Authors:  Francesco S Celi; Marina Zemskova; Joyce D Linderman; Nabeel I Babar; Monica C Skarulis; Gyorgy Csako; Robert Wesley; Rene Costello; Scott R Penzak; Frank Pucino
Journal:  Clin Endocrinol (Oxf)       Date:  2010-05       Impact factor: 3.478

2.  Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone.

Authors:  Tom Rodriguez; Victor R Lavis; Janet C Meininger; Asha S Kapadia; Linda F Stafford
Journal:  Endocr Pract       Date:  2005 Jul-Aug       Impact factor: 3.443

Review 3.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

Review 4.  Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer.

Authors:  Zeina C Hannoush; Roy E Weiss
Journal:  Rambam Maimonides Med J       Date:  2016-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.